 AMAG Pharmaceuticals, Inc. AMAG today provided an update regarding the potential impact of COVID-19 on the company. AMAG is committed to the health and safety of its employees, patients, healthcare providers, business partners and communities and is following the guidance from the Center for Disease Control CDC and Prevention and local public health authorities, including implementing a work from home policy for all employees. At this time, the companys supply chain has not been materially affected by COVID-19 and the company continues to closely monitor suppliers and supply levels. 